This is the gap that has been flagged by the latest Lancet study, which shows that compared to high income countries, where ...

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue ® , a biosimilar to Herceptin ® ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Children have returned to school and are bringing home stories about the things they learned and the friends they made. But some parents are concerned they could also be bringing home a tiny nuisance: ...

Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...